Preliminary results of phase II trial with combination of gemcitabine and oxaliplatin in elderly patients with advanced NSCLC.

被引：0
|
作者：
Buosi, R [1 ]
Poletti, S [1 ]
Cantele, V [1 ]
Piazza, S [1 ]
Torazzo, R [1 ]
Negru, E [1 ]
Vandone, A [1 ]
Alabiso, O [1 ]
机构：
[1] Osped Maggiore La Carita, Novara, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7348
引用
收藏
页码：703S / 703S
页数：1
相关论文
共 50 条
  • [31] Multicenter, prospective, randomized, phase-II trial of sequential and concurrent oral bexarotene in combination with chemotherapy, in previously untreated patients with advanced NSCLC.
    Bordoni, R
    Volas-Redd, G
    Zemsky, L
    Saleh, M
    Powell, C
    Harris, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 704S - 704S
  • [32] Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC) -: Results of a phase II study
    Louafi, Samy
    Boige, Valerie
    Ducreux, Michel
    Bonyhay, Luminita
    Mansourbakht, Touraj
    de Baere, Thierry
    Asnacios, Amani
    Hannoun, Laurent
    Poynard, Thierry
    Taieb, Julien
    CANCER, 2007, 109 (07) : 1384 - 1390
  • [33] Phase II trial evaluating combination, weekly gemcitabine and docetaxel in progressive, chemotherapy-exposed NSCLC: Preliminary results of OPN 003.
    Huang, CH
    Langer, CJ
    Millenson, MM
    Sherman, E
    Seldomridge, J
    Schol, J
    Rogatko, A
    Treat, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 694S - 694S
  • [34] Phase II trial evaluating combination, weekly gemcitabine and docetaxel-in progressive, chemotherapy-exposed NSCLC: Preliminary results of OPN 003
    Langer, C
    Huang, C
    Millenson, M
    Sherman, E
    Seldomridge, J
    Schol, J
    Rogatko, A
    Treat, J
    LUNG CANCER, 2005, 49 : S254 - S254
  • [35] Oxaliplatin and gemcitabine in advanced NSCLC: A multicentre phase 2 Australian study
    Broad, A
    Links, M
    Rosenthal, M
    Abraham, R
    Clarke, S
    Burns, I
    Dilulio, J
    Mitchell, P
    LUNG CANCER, 2005, 49 : S239 - S239
  • [36] Gemcitabine in combination with oxaliplatin as second-line therapy of advanced and metastatic NSCLC
    Alencar, A. J.
    Blaya, M.
    Raez, L.
    Farfan, N.
    Lopes, G.
    Walker, G.
    Flores, A.
    Macintyre, J.
    Rocha-Lima, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [37] Gemcitabine in aged NSCLC patients: preliminary results
    Bianco, V
    Gianni, W
    Pietropaolo, M
    Campisi, C
    Zanoni, M
    Gueli, N
    Marigliano, V
    Marchel, P
    ANNALS OF ONCOLOGY, 1998, 9 : 67 - 67
  • [38] A multicenter phase II trial with gemcitabine plus oxaliplatin as second line treatment in patients with advanced non-small cell lung cancer (NSCLC).
    Kouroussis, C
    Syrigos, K
    Potamianou, A
    Ziras, N
    Ziotopoulos, P
    Stergiou, J
    Ginopoulos, P
    Tselepatiotis, E
    Biozionelou, V
    Georgoulias, V
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 681S - 681S
  • [39] COMBINATION OF TRASTUZUMAB, OXALIPLATIN AND DOCETAXEL AS FIRST LINE TREATMENT IN HER2-POSITIVE ADVANCED BREAST CANCER PATIENTS: PRELIMINARY RESULTS OF A PHASE II TRIAL (HOT TRIAL)
    Amoroso, Domenico
    Donati, Sara
    Rondini, Marianna
    Valsuani, Chiara
    Siclari, Olimpia
    Puccetti, Cheti
    Tartarelli, Gianna
    Puccinelli, Paolo
    Giannessi, Piergiorgio
    Falcone, Alfredo
    Camerini, Andrea
    ANNALS OF ONCOLOGY, 2009, 20
  • [40] Lipoplatin plus gemcitabine versus cisplatin plus gemcitabine in NSCLC: Preliminary results of a phase III trial
    Boulikas, T.
    Mylonakis, N.
    Sarikos, G.
    Angel, J.
    Athanasiou, A.
    Politis, G.
    Rapti, A.
    Rassidakis, A.
    Karabatzaki, M.
    Anyfantis, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345